Skip to main content
Fig. 4 | Journal of Neuroinflammation

Fig. 4

From: Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis

Fig. 4

Localization and effect of GW559090 treatment on myeloid cells. a There were more myeloid cells (CD4-Iba-1+ cells) present within the inner retinal (R) layers in Veh group (× 400). b There were reduced levels of CD4+ T cells observed within the vitreous (V) and only very limited numbers of myeloid cells in the eyes of GW10 group (× 400). c Representative flow cytometry figure depicting CD11b+CD11c- myeloid population and CD11b+CD11c+ dendritic cells (DC) from CD45+ cell gates in single live cells. d Level of DCs in each treatment group illustrating a decrease of DCs in the eyes treated with Dex and GW10 compared to the control. e Representative flow cytometry figures illustrating inflammatory monocytes/macrophages (Ly6C+) and resident monocytes/macrophages (Ly6C-) from CD45+CD11b+CD11C-CD64+L6G- single live cell gate. f Comparing percentages of inflammatory and resident monocytes/macrophages between treatment groups (d, f). n = 3 data points per group from pooled two eyes for flow cytometric analysis. Data were from a single experiment which is representative of three experiments that were performed. Mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 using a two-tailed unpaired Student’s t test

Back to article page